Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hideko Endo is active.

Publication


Featured researches published by Hideko Endo.


Clinical Endocrinology | 1998

Familial isolated primary hyperparathyroidism with parathyroid carcinomas : clinical and molecular features

Katsuhiko Yoshimoto; Hideko Endo; Masaru Tsuyuguchi; Chisato Tanaka; Takehiko Kimura; Hiroyuki Iwahana; Genichi Kato; Toshiaki Sano; Mitsuo Itakura

Familial isolated primary hyperparathyroidism (FIHP) is a rare hereditary disorder. We present four patients from a single family with FIHP, and genetic analysis of their parathyroid adenomas and parathyroid carcinoma.


Spine | 2003

The pathogenesis of slippage and deformity in the pediatric lumbar spine: a radiographic and histologic study using a new rat in vivo model.

Tadanori Sakamaki; Koichi Sairyo; Shinsuke Katoh; Hideko Endo; Shinji Komatsubara; Toshiaki Sano; Natsuo Yasui

Study Design. Rat lumbar spines with posterior destabilizing surgery were evaluated radiographically and histologically. Objectives. To create an appropriate rat model showing the vertebral slippage and deformities frequently observed in pediatric patients with spondylolysis, and to clarify their pathogenesis. Summary of Background Data. There are controversial hypotheses regarding the pathogenesis of slippage and deformities of the pediatric spine with pars defects. Furthermore, there is no appropriate animal model mimicking those conditions. Methods. After posterior destabilizing surgery, the lumbar spines of young (4-week-old) and adult (26-week-old) rats were radiographically examined at weekly intervals during 3 weeks, and histologically 3 weeks after the surgery. Results. Slippage occurred in the young rats, but not in the adult rats. In the young rats, 7.2% slippage was observed 1 week after the surgery, whereas the slippage in the adult rats was 0%. The difference in percentage of slippage between the two groups was significant (P < 0.05). Lumbar deformity also was seen in the young rats, but not in the adult rats. The lumbar index of L6, as an indicator of L6 rounding, was 91.7% immediately after surgery. It had decreased to 87.7, 84.6, and 74%, respectively, 1, 2, and 3 weeks after surgery. Histologic examination showed growth plate injury in the young group and pronounced disc degeneration in the adult group. Conclusions. The young rat with posterior destabilizing surgery was an appropriate animal model, mimicking the slippage and deformities radiographically seen in pediatric patients with spondylolysis. The histologic examination indicated that vertebral growth plate impairment was the basic lesion causing such slippage and deformities in pediatric spines.


Endocrine Pathology | 2009

Clinicopathological Characterization of TSH-Producing Adenomas: Special Reference to TSH-immunoreactive but Clinically Non-functioning Adenomas

Elaine Lu Wang; Zhi Rong Qian; Shozo Yamada; Mustafizur Rahman; Naoko Inosita; Teruyoshi Kageji; Hideko Endo; Eiji Kudo; Toshiaki Sano

Thyrotropin (thyroid-stimulating hormone (TSH))-producing pituitary adenomas have been known to be quite variable in clinical features covering from typical functioning TSH-producing adenomas (FTSHomas) associated with hyperthyroidism to clinically silent TSH cell adenomas (STAs) that are apparently unassociated with hyperthyroidism. It is important to distinguish STAs from other types of clinically non-functioning adenomas for adequate postoperative managements. However, because of rareness of TSH-producing adenomas, their histopathological features linking to the clinical manifestations have not been well characterized. Herein, we investigated clinical and histopathological findings to characterize 29 TSH-producing adenomas including 20 FTSHomas and nine STAs. Clinical symptoms of the patients with STAs included headache, visual defect, vertigo, and nausea. All STAs and 19 FTSHomas were macroadenoma. The average tumor size of STAs was significantly larger than that of FTSHomas (P < 0.05). The invasiveness was detected in 33% STAs and in 20% FTSHomas. Both STAs and FTSHomas showed a variety of morphological features and immunohistochemical profiles. Chromophobic polygonal or short-spindled tumor cells usually proliferated in a diffuse pattern, while they exhibited globoid or whorl-like appearance with intertwined cytoplasmic processes in both subgroups. Stromal fibrosis and calcification were often noted. Their nuclei were somehow pleomorphic. Ultrastructural features of all four STAs examined were similar to those of normal thyrotrophs. Thus, STAs and FTSHomas were indistinguishable by histology alone. Immunohistochemically, the number of TSH-positive cells in individual FTSHomas was highly various. Six tumors showed only a few TSH-positive cells (1–5%), and three were negative for TSH by conventional method without antigen retrieval. After proteinase K treatment, these tumors turned out TSH positive. As defined, STAs were TSH positive in more than 20% of tumor cells and three of them in more than 50%. Growth hormone- and/or prolactin-positive cells were detected in 55% STAs and 63% FTSHomas. Both pituitary-specific transcription factor 1 and GATA-binding protein 2 were expressed in all STAs and 20 FTSHomas. Membranous somatostatin receptor (SSTR)-2A immunoreactivity was found in 89% STAs and 94% FTSHomas, whereas SSTR5 was positive in 78% of both STAs and FTSHomas. MIB-1 labeling index was related to tumor invasiveness and tumor size (P < 0.05, P = 0.09, respectively). Thus, although both STAs and FTSHomas showed unique histopathological features distinct from other type adenomas, these two subgroups were indistinguishable by histopathology. Immunohistochemistry for TSH by use of antigen retrieval, transcription factors, and SSTRs may be useful to confirm STAs and to determine the postoperative therapy among various kinds of clinically non-functioning adenomas.


Pathology International | 2004

Unique cell membrane expression of topoisomerase-II alpha as a useful diagnostic marker of liposarcoma

Hideko Endo; Mitsuyoshi Hirokawa; Naozumi Ishimaru; Yasushi Tanaka; Michiko Yamashita; Mika Sakaki; Yoshio Hayashi; Toshiaki Sano

Topoisomerase‐II alpha (Topo‐II alpha) is known as a cell cycle‐related intranuclear marker. To the best of our knowledge, the expression of Topo‐II alpha on extranuclear sites has not been reported. The aim of the present study was to determine the usefulness of Topo‐II alpha immunostaining for detecting the lipoblasts that are essential to diagnosing liposarcoma. Surgical specimens, including benign lipomatous tumors (four cases), well‐differentiated liposarcomas (three cases), myxoid liposarcomas (six cases), pleomorphic liposarcomas (two cases), dedifferentiated liposarcomas (two cases), myxoid malignant fibrous histiocytomas (six cases), and one case of mesenteric panniculitis, were studied. Samples were immunostained using antibodies for Topo‐II alpha, S‐100 protein and Ki‐67. In addition, we used the western blot method to investigate immunohistochemical‐affinity in adipocytes. Mature adipocytes and lipoblasts in all of the benign and malignant lipomatous tumors intensively expressed cell contours positivity for Topo‐II alpha. Cytoplasm of the lipoblasts occasionally reacted to the antibody and highlighted intracytoplasmic small unilocular, multivacuolated, or bubble‐like patterns. Western blot analysis confirmed a 70 kDa product reactive to Topo‐II alpha in the cell membrane fragment of mature adipocytes. S‐100 protein expressed adipocytes and lipoblasts, but the detection of lipoblasts was not as easy as in Topo‐II alpha immunostaining. Immunoreactivity of Ki‐67 was limited to the nuclei, and the nuclear labeling index of Ki‐67 correlated with that of Topo‐II alpha. The immunoreactivity of Topo‐II alpha for lipoblasts was more sensitive and obvious than those of S‐100 protein. Immunostaining using the antibody for Topo‐II alpha seems to be useful in recognizing lipoblasts that have been overlooked in hematoxylin–eosin‐stained preparations, and is a useful marker for diagnosing liposarcoma.


Chemico-Biological Interactions | 2018

Neutrophil depletion protects against zomepirac-induced acute kidney injury in mice

Shohei Yamashita; Shingo Oda; Hideko Endo; Koichi Tsuneyama; Tsuyoshi Yokoi

Acyl glucuronide (AG) metabolites of carboxylic acid-containing drugs have been implicated in drug toxicity. Zomepirac (ZP) is a non-steroidal anti-inflammatory drug that was withdrawn from the market because of anaphylactic reactions and renal injury. We recently established a novel mouse model of ZP-induced kidney injury by increasing zomepirac acyl-glucuronide (ZP-AG) concentration via pretreatment with tri-O-tolyl phosphate, a nonselective esterase inhibitor, and l-buthionine-(S,R)-sulfoximine, a glutathione synthesis inhibitor. Although we have shown that ZP-AG is responsible for ZP-induced kidney injury in mice, the exact pathogenic mechanisms of ZP-induced kidney injury have not been investigated yet. In this study, we aimed to investigate the role of immune cells in the pathogenesis of ZP-induced kidney injury, as a representative of AG toxicity. We found that the counts of neutrophils and inflammatory monocytes increased in the blood of mice with ZP-induced kidney injury. However, clodronate liposome- or GdCl3-induced monocyte and/or macrophage depletion did not affect blood urea nitrogen and plasma creatinine levels in mice with ZP-induced kidney injury. Neutrophil infiltration into the kidneys was observed in mice with ZP-induced kidney injury, whereas anti-lymphocyte antigen 6 complex, locus G (Ly6G) antibody pretreatment prevented the renal neutrophil infiltration and partially protected against ZP-induced kidney injury. The mRNA expression of neutrophil-infiltrating cytokines and chemokines, interleukin-1α and macrophage inflammatory protein-2α, increased in mice with ZP-induced kidney injury, whereas pretreatment with anti-Ly6G antibody resulted in a marked reduction of their expression. These results suggest that ZP-AG might be involved in kidney injury, partly via induction of neutrophil infiltration. Therefore, this study may provide an important understanding on toxicological role of ZP-AG in vivo that helps to understand toxicity of AG metabolites.


Orthopedics | 2014

Reverse Adipofascial Flap After Resection of a Malignant Perineurioma of the Forearm

Mitsuhiko Takahashi; Tokio Kasai; Toshihiko Nishisho; Michihiro Takai; Hideko Endo; Takanori Hirose; Koichi Sairyo

The authors describe a patient with recurrent perineurioma arising in the subcutaneous tissue of the dorsal forearm and extending along the forearm fascia. Soft tissue perineurioma is a rare, originally benign peripheral nerve sheath neoplasm arising from the perineurium, a protective cell barrier surrounding the individual fascicles in peripheral nerves. Perineurioma has only recently been recognized as an entity distinct from other nerve sheath tumors, such as schwannoma and neurofibroma, with unique morphologic, ultrastructural, and immunoreactive features. The recurrent tumor had converted into malignant perineurioma, defined as increased nuclear pleomorphism and cellularity. The ill-marginate feature extending along the fascia required wide resection, leaving a substantial defect on the distal forearm. Surgical repair of large forearm skin defects is challenging because of limited skin extensibility for flap creation, the prominence of the site in terms of aesthetic outcome, and the risk of damage to extrinsic muscles that control delicate hand movements. The reverse forearm adipofascial flap, which was based on distal perforators of the radial artery, was suitable for the current case to cover the exposed myotendinous junctions of the forearm extensor muscles. This flap did not sacrifice skin, a major vessel, or skeletal muscles, and preserved function at both the donor and the recipient sites. The texture of the graft was similar to that of the surrounding skin. The clinical and histopathologic features of this rare tumor are also described to aid in the differential diagnosis and as a reference for surgeons who treat soft tissue neoplasms and may encounter this type of soft tumor.


The Journal of Medical Investigation | 2000

Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori : follow-up study of 48 cases

Shahnaz Begum; Toshiaki Sano; Hideko Endo; Hitoshi Kawamata; Yoshihito Urakami


Pathology International | 2001

Case report: Sinonasal teratocarcinosarcoma.

Hideko Endo; Takanori Hirose; Kuwamura Ki; Toshiaki Sano


Histopathology | 2003

Cervical polyp with eccrine syringofibroadenoma‐like features

Hideko Endo; Mitsuyoshi Hirokawa; H Takahashi; Yoshiki Mikami; Toshiaki Sano


Internal Medicine | 1999

Biclonal lymphoplasmacytic immunocytoma associated with Crohn's disease.

Tomoko Hara; Shuji Ozaki; Masaaki Kosaka; Soichiro Fujiwara; Yuji Wakahara; Hideko Endo; Shingo Wakatsuki; Toshio Matsumoto

Collaboration


Dive into the Hideko Endo's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shozo Yamada

University of Tokushima

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Eiji Kudo

University of Tokushima

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge